Sleep-disordered breathing (SDB), ranging from habitual snoring to severe obstructive sleep apnea (OSA), is highly prevalent and represents a growing global healthcare burden. Besides disrupting sleep, SDB leads to detrimental outcomes such as excessive daytime sleepiness, neurocognitive impairment, and increased cardiometabolic morbidities.
In the Research Topic Volume I and II, we observed the technology developments that enable rapid innovations in the field of SDB. Simple diagnostic methods and novel disease management solutions strongly suggest that the SDB diagnostics and management are moving from a one-size-fits-all approach to precision sleep medicine.
To build on the success of Volume I and Volume II presenting outstanding works in the field, the Volume III aims to expand on the recent developments in the field of sleep medicine.
Possible topics of interest include, but are not limited to:
1. Novel insights on pathophysiology of OSA from physiological signals collected in standard sleep studies;
2. Novel signal acquisition and sensor technologies;
3. Alternative polysomnography metrics and analyses;
4. Minimally invasive data collection for screening and long-term follow-up of SDB
5. Artificial intelligence and machine learning- based signal analysis approach;
6. Biomarkers and phenotyping-based prediction models on treatment outcomes;
7. Big data approaches and telemedicine in sleep medicine;
8. Emerging technologies to provide alternative treatment options for better treatment adherence and clinical outcomes;
9. Disease management approaches encompass phenotyping, and endotyping for better patient characterization including disease severity, daytime symptoms, as well as comorbidity conditions;
10. Patient-reported outcome measures assessment and sleep disparities studies;
We are interested in original works, protocols, literature reviews, meta-analyses, perspectives and expert consensus related to sleep disorders with a specific focus on SDB.
• Novel Technologies in the Diagnosis and Management of Sleep-Disordered Breathing
• Novel Technologies in the Diagnosis and Management of Sleep-Disordered Breathing: Volume II
Keywords:
Obstructive sleep apnea, Oximetry Pulse wave, Ambulatory sleep test, Autonomic sleep staging, Artificial Intelligence, Machine learning, non-PAP therapy, Phenotyping, Endotype, Network Physiology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Sleep-disordered breathing (SDB), ranging from habitual snoring to severe obstructive sleep apnea (OSA), is highly prevalent and represents a growing global healthcare burden. Besides disrupting sleep, SDB leads to detrimental outcomes such as excessive daytime sleepiness, neurocognitive impairment, and increased cardiometabolic morbidities.
In the Research Topic Volume I and II, we observed the technology developments that enable rapid innovations in the field of SDB. Simple diagnostic methods and novel disease management solutions strongly suggest that the SDB diagnostics and management are moving from a one-size-fits-all approach to precision sleep medicine.
To build on the success of Volume I and Volume II presenting outstanding works in the field, the Volume III aims to expand on the recent developments in the field of sleep medicine.
Possible topics of interest include, but are not limited to:
1. Novel insights on pathophysiology of OSA from physiological signals collected in standard sleep studies;
2. Novel signal acquisition and sensor technologies;
3. Alternative polysomnography metrics and analyses;
4. Minimally invasive data collection for screening and long-term follow-up of SDB
5. Artificial intelligence and machine learning- based signal analysis approach;
6. Biomarkers and phenotyping-based prediction models on treatment outcomes;
7. Big data approaches and telemedicine in sleep medicine;
8. Emerging technologies to provide alternative treatment options for better treatment adherence and clinical outcomes;
9. Disease management approaches encompass phenotyping, and endotyping for better patient characterization including disease severity, daytime symptoms, as well as comorbidity conditions;
10. Patient-reported outcome measures assessment and sleep disparities studies;
We are interested in original works, protocols, literature reviews, meta-analyses, perspectives and expert consensus related to sleep disorders with a specific focus on SDB.
•
Novel Technologies in the Diagnosis and Management of Sleep-Disordered Breathing •
Novel Technologies in the Diagnosis and Management of Sleep-Disordered Breathing: Volume II
Keywords:
Obstructive sleep apnea, Oximetry Pulse wave, Ambulatory sleep test, Autonomic sleep staging, Artificial Intelligence, Machine learning, non-PAP therapy, Phenotyping, Endotype, Network Physiology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.